Leukemia and Lymphoma Society
Investor profile
Venture capital
Leukemia and Lymphoma Society has backed 1 European tech company across 1 funding round in 2022, joining rounds totalling €96M. Most active in Healthtech. Data as of Nov 2026.
Deals
1
distinct rounds
Companies
1
backed
Active span
2022
1 yr
Total round €
€96M
sum of rounds joined
Deals by year
distinct rounds / yearLeukemia and Lymphoma Society — deals by year — interactive chart.
Data table
| Leukemia and Lymphoma Society — deals by year | |
|---|---|
| 2022 | 1 |
Top sectors
by dealsLeukemia and Lymphoma Society — top sectors — interactive chart.
Data table
| Leukemia and Lymphoma Society — top sectors | |
|---|---|
| Healthtech | 1 |
Stages
by dealsLeukemia and Lymphoma Society — stages — interactive chart.
Data table
| Leukemia and Lymphoma Society — stages | |
|---|---|
| Other | 1 |
Countries
by dealsLeukemia and Lymphoma Society — countries — interactive chart.
Data table
| Leukemia and Lymphoma Society — countries | |
|---|---|
| France | 1 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared roundsPortfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Imcheck Therapeutics | France | 1 | €96M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Imcheck Therapeutics | Other | €96M | 2022-06 |